Charmaine Lok is a Professor of Medicine at the Faculty of Medicine, University of Toronto and Senior Scientist at the Toronto General Hospital Research Institute. She is also associated with the Department of Clinical Epidemiology and Biostatistics, Faculty of Health Sciences, McMaster University. Dr. Lok is the Medical Director of both the Chronic Kidney Diseases and Hemodialysis Vascular Access Programs at the Toronto General Hospital.
Dr. Lok is a clinical trialist with a research focus on chronic kidney disease (CKD) and endstage kidney disease (ESKD) outcomes. She has a special interest in improving hemodialysis vascular access outcomes, improving neuromuscular function and mobility in CKD and reducing cardiovascular events and mortality in CKD/ESRD. She is also active in raising awareness of CKD and ESRD and its importance in population health.
Nephrol Dial Transplant. 2019 Feb 14;:
Kidney Int. 2019 Jan;95(1):38-49
Cardiovascular magnetic resonance left ventricular strain in end-stage renal disease patients after kidney transplantation.
J Cardiovasc Magn Reson. 2018 Dec 17;20(1):83
Comparison between Surgical and Endovascular Hemodialysis Arteriovenous Fistula Interventions and Associated Costs.
J Vasc Interv Radiol. 2018 Oct 04;:
Can J Kidney Health Dis. 2018;5:2054358118791148
J Vasc Access. 2018 Jul 25;:1129729818787994
Cardiovasc Intervent Radiol. 2018 Jul 13;:
Improving precision in prediction: Using kidney failure risk equations as a potential adjunct to vascular access planning.
J Vasc Access. 2018 Jul 01;:1129729818786630
Clin J Am Soc Nephrol. 2018 May 18;:
Semin Dial. 2018 Apr 19;:
Senior Scientist, Toronto General Hospital Research Institute (TGHRI)
Associate Professor, Department of Medicine, University of Toronto
Faculty, Institute of Health Policy, Management & Evaluation, University of Toronto
Department of Clinical Epidemiology and Biostatistics, Faculty of Health Sciences, McMaster University